| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.9 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |